This review discusses current clinical advancements in oncolytic viral therapy, with a focus
on the viral platforms approved for clinical use and highlights the benefits each platform …

Over the last 60 years an eclectic collection of microbes has been tested in a variety of pre-
clinical models as anti-cancer agents. At the forefront of this research are a number of virus …

Oncolytic viruses (OVs) are engineered and/or evolved to propagate selectively in
cancerous tissues. They have a dual mechanism of action; direct killing of infected cancer …

Oncolytic virus (OV) therapy is an anti-cancer approach that uses viruses that preferentially
infect, replicate in and kill cancer cells. Vesicular stomatitis virus (VSV, a rhabdovirus) is an …

Engineered oncolytic viruses are used clinically to destroy cancer cells and have the ability
to boost anticancer immunity. Phosphatase and tensin homolog deleted on chromosome 10 …

In the present paper, we address by means of mathematical modeling the following main
question: How can oncolytic virus infection of some normal cells in the vicinity of tumor cells …

Oncolytic viruses are under intense development and have earned their place among the
novel class of cancer immunotherapeutics that are changing the face of cancer therapy …

Oncolytic virotherapy uses replication-competent virus as a means of treating cancer.
Whereas this field has shown great promise as a viable treatment method, the limited spread …

Theranostics cover emerging technologies for cell biomarking for disease diagnosis and
targeted introduction of drug ingredients to specific malignant sites. Theranostics …

Introduction: Oncolytic viruses represent a novel treatment modality that is unencumbered by
the standard resistance mechanisms limiting the therapeutic efficacy of conventional …